| Digestive System Adenocarcinoma studied in …STUDIED_INderived200 of 5,067show all (up to 200) |
|---|
| → studied in | NCT00423306Phase 2 · completed A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03897543Phase 1/Phase 2 · completed ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04175912Phase 2 · active not recruiting Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04548752Phase 2 · active not recruiting Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04605913Phase 1/Phase 2 · active not recruiting Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04751370Phase 2 · active not recruiting Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Rectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05176223Phase 2 · completed 68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05731271Phase 1/Phase 2 · active not recruiting A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Colorectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05877599Phase 1 · recruiting A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06203600Phase 2/Phase 3 · recruiting Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06605664Phase 2 · recruiting Hyperpolarized 13C-MRI in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy, Atezolizumab, and Bevacizumab · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06608927Phase 3 · active not recruiting Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07212491enrolling by invitation Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07529808Phase 1/Phase 2 · recruiting Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07551596Phase 2 · recruiting Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Colorectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07603375Phase 2 · recruiting Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07607769recruiting MONTEROSA - Italian Multicenter Observational Study to Evaluate Time to Clinical Hepatic Decompensation, Quality of Life, Effectiveness, and Safety of Tremelimumab Plus Durvalumab in Patients With Advanced or Unresectable Hepatocellular Carcinoma Who Have Received no Prior Systemic Treatment. · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07845617recruiting Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07847671Phase 2 · not yet recruiting Fecal Microbiota Transplantation With QL1706 Plus Bevacizumab for Advanced HCC · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03030404completed Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | Hereditary Gastric Diffuse Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05007106Phase 2 · completed MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05482893Phase 1/Phase 2 · recruiting Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study) · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05540925completed Vascular Invasion Prediction Via a Multimodal Model Supports Re-staging of Early-stage Hepatocellular Carcinoma · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05965999recruiting Lucid Registry Study · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06388967recruiting Pancreatic Cancer Detection Consortium · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06726161Phase 1/Phase 2 · recruiting Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06997497Phase 3 · recruiting A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012) · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Colon Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07227012Phase 1/Phase 2 · recruiting Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body. · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07277413Phase 1 · recruiting A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07305428NA · recruiting Downstaging Unresectable Hepatocellular Carcinoma to Resectable Disease With Combined Immunotherapy and Stereotactic Beamed Radiotherapy: a Pilot Study · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07392892Phase 2/Phase 3 · recruiting Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07621718Phase 3 · recruiting Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 ) · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07691762Phase 3 · not yet recruiting A Study of TACE in Combination With SHR-8068, Adebrelimab, and Bevacizumab Versus TACE in Participants With Incurable Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07844057Phase 2 · not yet recruiting First-line Treatment in Locally Advanced or Metastastic Small Bowel Adenocarcinoma · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | Small Intestinal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07845266Phase 1 · completed Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GKL-006 Injection in Combination With TACE in Unresectable Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02498613Phase 2 · active not recruiting A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04123379Phase 2 · active not recruiting Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC) · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04858334Phase 2 · recruiting APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05610163Phase 2/Phase 3 · active not recruiting Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation and Continuing Response · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Rectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06005493Phase 1/Phase 2 · recruiting Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06084234Phase 4 · recruiting National Liver Cancer Screening Trial · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06218914Phase 1 · recruiting Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06428409Phase 1/Phase 2 · recruiting A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A) · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06618664Phase 3 · recruiting A Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma (KYLIN-02) · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06737913Phase 2 · recruiting HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06989437Phase 2/Phase 3 · recruiting A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07562152Phase 3 · recruiting Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07670312Phase 1/Phase 2 · recruiting Evaluation of XYA02 in Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04145141completed National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05152147Phase 3 · active not recruiting A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06047379Phase 1/Phase 2 · recruiting Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06123338Phase 2 · recruiting A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06882746Phase 1 · terminated A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07838415recruiting Multimodalomics-based Construction of Spatiotemporal Characteristics of Dynamic Liver Cancer Microenvironment to Characterize the Clinical Application of Immune Mechanisms in Liver Cancer · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07839767recruiting Treatment Selection by 3D Bioprinting Liver Model to Prevent Liver Cancer Recurrence · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07840092recruiting Biomarker Validation for Treatment Efficacy and Recurrence Prediction in Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06102902Phase 1 · recruiting Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Colorectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06253650Phase 2 · recruiting Adjuvant TRastuzumab Deruxtecan for HER2-positive Gastroesophageal Cancer With Persistence of miNImal Residual Disease · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | HER2-Positive Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06915753Phase 1 · recruiting Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07252232Phase 3 · recruiting Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC) · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07291076Phase 1/Phase 2 · recruiting A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206) · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07344220Phase 2 · enrolling by invitation Metastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye Conjugate · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07835737Phase 1/Phase 2 · not yet recruiting Safety and Efficacy of Folic Acid Combined With Atezolizumab and Bevacizumab as First-Line Therapy for Unresectable Hepatocellular Carcinoma · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07836309not yet recruiting TACE in Combination With Tislelizumab and Lenvatinib for Advanced HCC (CHANCE2602) · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07836530Phase 3 · not yet recruiting Study Comparing BGB-B2033 With Sorafenib or Lenvatinib in Relapsed Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07836712Phase 2 · not yet recruiting Multiple Adjunct Therapies to Improve Immunotherapy Treatment in Patients With Locally Advanced or Metastatic Melanoma or Advanced Hepatocellular Cancer · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04291651recruiting UCSF PANC Cyst Registry · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06066138Phase 1 · recruiting A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06109272Phase 2/Phase 3 · active not recruiting A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC) · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06128551Phase 1/Phase 2 · recruiting Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06445062Phase 1/Phase 2 · recruiting Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06858813Phase 1 · recruiting A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC) · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07409272Phase 3 · recruiting A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07488676Phase 1/Phase 2 · recruiting A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07596134NA · not yet recruiting Multimodal Thermal Therapy With Targeted and Immunotherapy for Untreated Unresectable HCC · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07619521Phase 1/Phase 2 · recruiting Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07769502Phase 2 · recruiting A Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults Participants With Pancreatobiliary Cancers · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07835087NA · recruiting Image-Guided Platform-Assisted Sentinel Lymph Node Retrieval in Early Gastric Cancer · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | Early Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04295811NA · active not recruiting Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04543071Phase 2 · active not recruiting Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06005740Phase 1 · active not recruiting A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06040099Phase 2 · active not recruiting A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARE · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06929845NA · recruiting Organoid Models of Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07200141Phase 2 · recruiting Simultaneous Boost in Neoadjuvant Radiotherapy for Rectal Cancer · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Rectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07629960Phase 1/Phase 2 · recruiting A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07639138Phase 2 · recruiting Lenalidomide Plus Targeted Therapy and Immunotherapy for Refractory HCC · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07645651Phase 1 · recruiting Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07793695Phase 2 · recruiting Oral Zinc Supplementation Combined With Targeted Immunotherapy for Unresectable or Advanced Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07829926Phase 2 · not yet recruiting Lenvatinib Plus Tislelizumab With or Without Gefitinib for Advanced Liver Cancer · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831330Phase 2 · not yet recruiting Albumin-bound Paclitaxel (II) in Combination With Gemcitabine as First Line Therapy for Metastatic Pancreatic Cancer · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07832006Phase 2 · recruiting Irreversible Electroporation Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02874885active not recruiting Circulating Tumor Cells in Patients With Locally Advanced Rectal Cancer · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Rectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03776487Phase 2 · active not recruiting Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06954116Phase 2 · recruiting Iparomlimab and Tuvonralimab as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With High Risk of Recurrence · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07435038Phase 1/Phase 2 · recruiting Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07450859Phase 2 · recruiting A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07627191early Phase 1 · recruiting GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07827053Phase 2 · not yet recruiting Clinical Study of Radiotherapy Combined With Adebrelimab and NALIRIFOX for Conversion Therapy in Locally Advanced Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07827807Phase 2 · not yet recruiting PEARL Trial: Partial TACE Enhancing Anti-tumor Response With Lenvatinib in Unresectable HCC · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07828236Phase 1 · not yet recruiting PHASE 1 TRIAL OF Lm-LLO-TT AND GEMCITABINE IN UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07829185Phase 1 · not yet recruiting Modified FOLFIRINOX and Pentamidine in Advanced and Metastatic Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02851784Phase 2/Phase 3 · recruiting Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04152499Phase 1/Phase 2 · active not recruiting Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01) · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06275737NA · recruiting POP-UP: a Single-arm, Two-cohort Study: an 8-week Trimodal Pre-habilitation Program for Patients With Pancreatic Ductal Adenocarcinoma and Oesogastric · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07020117Phase 1 · recruiting A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Colorectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07027436Phase 3 · recruiting Radiation Therapy Followed by Durvalumab (MEDI4736) and Tremelimumab And Surgery Versus Radiation Therapy Followed by Surgery for Resectable Hepatocellular Carcinoma. · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07349537Phase 1 · recruiting Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07780305not yet recruiting ABCSG R07 Rectal Cancer Registry · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | Rectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07824583NA · recruiting A Study Evaluating a New Radiation Treatment Workflow (NGDS) · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07824765not yet recruiting Heterogeneity of Treatment Effects of Adding Locoregional Therapies to Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma (ISMIO-026) · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07825519NA · active not recruiting Effectiveness of Enhanced Web-Based Health Education on Self-Care Practices and Quality of Life Among Patients With Hepatocellular Carcinoma Undergoing TACE · condition mapped PROBABILISTIC · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03460080completed Diagnostic Value of AFP-L3 and PIVKA-II in HCC · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05081024recruiting Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Rectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06324357Phase 1/Phase 2 · recruiting Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06427941Phase 1/Phase 2 · recruiting A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06574620NA · recruiting Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07811193Phase 2 · recruiting A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Colorectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07823348Phase 3 · not yet recruiting JS207 Plus JS007 Versus Toripalimab Plus Bevacizumab as First-Line Treatment for Advanced Liver Cancer · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04165772Phase 2 · recruiting Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Rectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05692596active not recruiting The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05908786Phase 1/Phase 2 · terminated A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06007846Phase 2/Phase 3 · recruiting A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06412510Phase 1/Phase 2 · active not recruiting Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06687603NA · recruiting Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06730373Phase 2 · recruiting First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2) · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | HER2-Positive Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06968195Phase 1 · suspended Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07255001NA · recruiting Using Strength Tests to Better Understand How Pancreatic Cancer Affects Muscle Mass and Quality of Life · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07429487NA · recruiting Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07540832Phase 1/Phase 2 · not yet recruiting A Study of WGI-0301 Plus Lenvatinib in Patients With Advanced HCC · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07702292Phase 2 · recruiting [68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07776080Phase 2 · recruiting Iparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and HAIC for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01300143Phase 2 · completed Association of Conformational High-dose Radiotherapy and of Hyperselective Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074513Phase 2 · active not recruiting Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Appendix Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03533582Phase 3 · active not recruiting Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Childhood Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04111172Phase 2 · suspended A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04140526Phase 1/Phase 2 · active not recruiting Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04248452Phase 3 · active not recruiting Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04380545Phase 1/Phase 2 · recruiting Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04721132Phase 2 · active not recruiting Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver Cancer · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04921904Phase 1/Phase 2 · completed Abemaciclib Plus Ramucirumab for Esophageal/Gastroesophageal Junction Ca · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05059444recruiting ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05197322Phase 2 · active not recruiting NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | Colon Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05482516Phase 3 · recruiting Evaluating Novel Therapies in ctDNA Positive GI Cancers · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Colon Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05799274Phase 1 · active not recruiting Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05858736Phase 1 · completed Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05883644Phase 3 · active not recruiting Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC) · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06732388Phase 2 · recruiting Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06789198Phase 1 · recruiting Peptide Vaccine for Fibrolamellar Hepatocellular Carcinoma Patients and Other Tumor Entities Carrying the Driver Fusion DNAJB1-PRKACA · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07365839Phase 1 · withdrawn Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07491445Phase 3 · recruiting Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07615374NA · recruiting Laparoscopic-endoscopic Surgery Assisted Sentinel Lymph Node Navigation Surgery for Early Gastric Cancer · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | Early Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07818018Phase 1/Phase 2 · recruiting A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07818070Phase 3 · not yet recruiting A Trial of ONO-4578 Versus Placebo in Combination With Nivolumab and Chemotherapy in Participants With Gastric Cancer, Esophagogastric Junction Cancer, or Esophageal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01585805Phase 2 · active not recruiting Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02521285Phase 2 · active not recruiting Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02772003Phase 1 · active not recruiting DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03878550active not recruiting Case-Control Study of the Glycotest™ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04665947early Phase 1 · active not recruiting First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05077800Phase 2 · active not recruiting FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05365581Phase 1 · recruiting A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05753748NA · recruiting Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06309485Phase 2 · recruiting Phase 2 Study of WGI-0301 for Advanced HCC · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06764875Phase 3 · recruiting A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | HER2-Positive Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07081360Phase 3 · recruiting Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | Periampullary Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07132541Phase 1 · recruiting Saleh's Technique for Pancreaticojejunostomy (Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate) · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | Periampullary Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07148830NA · recruiting Mesopancreatic Excision for Pancreatic Duct Adenocarcinoma. · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07673887Phase 3 · recruiting A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07714538recruiting Breath Research Narrow Validation for Gastrointestinal Cancer Detection · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07815054not yet recruiting Efficacy Evaluation of Microwave Ablation Assisted by Diaphragm Hydrodissection for Hepatocellular Carcinoma and Comparative Analysis With Surgical · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01142388Phase 2 · active not recruiting Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04514497Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04661150Phase 2 · completed A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04864054Phase 1/Phase 2 · recruiting GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05111626Phase 3 · terminated Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06266299Phase 1 · recruiting A Study of KK2269 in Adult Participants With Solid Tumors · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06524973NA · recruiting Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06563947Phase 2 · recruiting Oral Fecal Microbiota Transplantation in Advanced Hepatocellular Carcinoma After Progression on ICI-TKI Therapy · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07000253Phase 2 · recruiting Timing of Comprehensive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07161869recruiting Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III) · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Biliary Tract Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07677774NA · recruiting GPC3-Targeted PET/CT in Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07812805Phase 1 · recruiting SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07813572Phase 3 · not yet recruiting ZG005 Plus Bevacizumab vs Sintilimab Plus Bevacizumab as First-Line Therapy for Advanced Hepatocellular · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07814014recruiting Real-world Insight Into Systemic Therapies for HCC: Single-center Study · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01660971Phase 1 · active not recruiting Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02962063Phase 1/Phase 2 · active not recruiting Durvalumab, an Anti-PDLI Antibody, and Tremelimumab, an Anti-CTLA4 Antibody, and Chemoradiation Before Surgery for Esophageal Cancer · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02968810Phase 2 · completed Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05685602Phase 1 · suspended CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05715931Phase 2 · active not recruiting Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05968326Phase 2 · active not recruiting A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06597721Phase 1 · recruiting ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06696768Phase 1 · recruiting Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Colorectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07147231Phase 1/Phase 2 · recruiting Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Colorectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07272083recruiting New Diagnostic Criteria in the Evaluation Response to Ablation Treatment of Hepatocellular Carcinoma Nodules · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07431281Phase 3 · recruiting Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2 · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00878163Phase 1 · active not recruiting GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02997228Phase 3 · active not recruiting Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Colorectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03715933Phase 1 · recruiting Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas · condition mapped ONTOLOGY_EXACT · 5,067 trials mapped (1,743 active) | — | — | Colorectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03937830Phase 2 · active not recruiting Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04662879NA · active not recruiting Early Detection Initiative for Pancreatic Cancer · condition mapped ALIAS · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06861452Phase 1/Phase 2 · recruiting Phase I/IIa Study: RR001 Administered Following Chemotherapy Cycles for Patients With Locally Advanced Pancreatic Carcinoma · condition mapped CURATED_BROADER · 5,067 trials mapped (1,743 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |